MedPath

Patient and Staff Safety During Aorto-iliac Revascularization Procedures Under Automated Fusion Imaging Guidance With Controls

Not Applicable
Terminated
Conditions
Patient and Staff Radiation Exposure During Aorto-iliac Endovascular Revascularization
Interventions
Device: Control with imaging guidance
Device: Control without imaging guidance
Registration Number
NCT03713450
Lead Sponsor
Nantes University Hospital
Brief Summary

Endovascular revascularization has revolutionized the field of vascular surgery and has become the first-choice treatment for peripheral arteries occlusive disease. However, the drawback of this technic is the X-ray exposure for both patients and staff and the iodinated contrast injection for the patient.

One way to reduce both radiation and contrast use is to use advanced imaging techniques allowing an overlay of a 3D vascular mask (from a pre-operative CT scan) onto the live X-ray image. This has been proven during endovascular aneurysm repair.

This advanced imaging application is currently available only in the latest expensive hybrid operating rooms, requires additional manoeuvre from the operator throughout the procedure, and may be X-rays and contrast consuming.

This trial will examine the clinical benefits based on patient and staff' radiation exposure during aorto-iliac revascularisation, of a new software imaging guidance, suitable for any theatre including those equipped with mobile C-arm, fully automated and with a radiation free overlay registration process.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Male or female aged 18 or older,
  • Patients scheduled for aorto iliac endovascular revascularisation,
  • Pre-operative CT scan.
Exclusion Criteria
  • Women of childbearing age,
  • Absence of preoperative CT scan,
  • Emergency procedures.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control with imaging guidanceControl with imaging guidance-
Control without imaging guidanceControl without imaging guidance-
Primary Outcome Measures
NameTimeMethod
Dose area productThe end of the procedure

Dose area product (DAP) by the end of the procedure.

Secondary Outcome Measures
NameTimeMethod
Number of DSA runsThe end of the procedure

Number of DSA runs by the end of the procedure.

Contrast volumeThe end of the procedure

Contrast volume (ml) by the end of the procedure.

Operative timeThe end of the procedure

Operative time (min) by the end of the procedure.

Operator exposureThe end of the procedure

Operator exposure (Sv) by the end of the procedure.

Air KermaThe end of the procedure

Air Kerma (mGy) by the end of the procedure.

Fluoroscopy timeThe end of the procedure

Fluoroscopy time (min) by the end of the procedure.

Trial Locations

Locations (1)

Nantes University Hospital, Vascular surgery, Institut du Thorax

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath